Reference
- Araujo M, et al. A case of fulminant Type 1 diabetes following anti-PD1 immunotherapy in a genetically susceptible patient. Immunotherapy 9: 531-535, No. 7, 9 Jun 2017. Available from: URL: https://doi.org/10.2217/imt-2017-0020 -PortugalCrossRefPubMedGoogle Scholar
Copyright information
© Springer International Publishing AG 2017